Literature DB >> 18392604

[Calcium oxalate stone formation. New pathogenetic aspects of an old disease].

G Wendt-Nordahl1, A P Evan, M Spahn, T Knoll.   

Abstract

Calcium oxalate (CaOx) urolithiasis is a very common disorder. Surprisingly, the pathogenetic mechanisms leading to CaOx stone formation have been largely unknown so far. The long-accepted simple explanation by an exceeding of the solubility product of lithogenic substances in the urine cannot sufficiently describe the complex processes. Deviating from the hypothesis that proclaims that the initial crystal deposition takes place in the lumens of renal tubules, new insights suggest a primary plaque formation in the interstitial space of the renal papilla. Initially, calcium phosphate (CaPh) crystals and organic matrix are deposited along the basement membranes of the thin loops of Henle and extend further in the interstitial space to the urothelium, constituting the so-called Randall's plaques that can be regularly found during endoscopy of CaOx-stone-forming patients. These CaPh crystals seem to be the origin for the development of future CaOx stones, which form by the attachment of further matrix molecules and CaOx from the urine to the plaque. The driving forces, the exact pathogenetic mechanisms, and the involved matrix molecules remain largely unknown. Possibly, completely different pathomechanisms lead to the common clinical diagnosis of"CaOx stone former."

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392604     DOI: 10.1007/s00120-008-1707-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  20 in total

1.  Impact of hypoxia and hypercapnia on calcium oxalate toxicity in renal epithelial and interstitial cells.

Authors:  Yanwei Cao; Sreedhar Sagi; Axel Häcker; Annette Steidler; Peter Alken; Thomas Knoll
Journal:  Urol Res       Date:  2006-04-22

2.  Urine calcium and volume predict coverage of renal papilla by Randall's plaque.

Authors:  Ramsay L Kuo; James E Lingeman; Andrew P Evan; Ryan F Paterson; Joan H Parks; Sharon B Bledsoe; Larry C Munch; Fredric L Coe
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

3.  Relationship among risk factors for nephrolithiasis, cardiovascular disease, and ethnicity: focus on a law enforcement cohort.

Authors:  Sandra L Ramey; Warren D Franke; Mack C Shelley
Journal:  AAOHN J       Date:  2004-03

4.  Endoscopic evidence of calculus attachment to Randall's plaque.

Authors:  Brian R Matlaga; James C Williams; Samuel C Kim; Ramsay L Kuo; Andrew P Evan; Sharon B Bledsoe; Fredric L Coe; Elaine M Worcester; Larry C Munch; James E Lingeman
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

5.  Stone formation is proportional to papillary surface coverage by Randall's plaque.

Authors:  Samuel C Kim; Fredric L Coe; William W Tinmouth; Ramsay L Kuo; Ryan F Paterson; Joan H Parks; Larry C Munch; Andrew P Evan; James E Lingeman
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

Review 6.  The role of Randall's plaques in the pathogenesis of calcium stones.

Authors:  Brian R Matlaga; Fredric L Coe; Andrew P Evan; James E Lingeman
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

7.  Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.

Authors:  A P Evan; S Bledsoe; E M Worcester; F L Coe; J E Lingeman; K J Bergsland
Journal:  Kidney Int       Date:  2007-09-26       Impact factor: 10.612

8.  Mechanism of formation of human calcium oxalate renal stones on Randall's plaque.

Authors:  Andrew P Evan; Fredric L Coe; James E Lingeman; Youzhi Shao; Andre J Sommer; Sharon B Bledsoe; Jennifer C Anderson; Elaine M Worcester
Journal:  Anat Rec (Hoboken)       Date:  2007-10       Impact factor: 2.064

9.  Calcium and oxalate concentrations in human renal tissue: the key to the pathogenesis of stone formation?

Authors:  R Hautmann; A Lehmann; S Komor
Journal:  J Urol       Date:  1980-03       Impact factor: 7.450

10.  The role of overweight and obesity in calcium oxalate stone formation.

Authors:  Roswitha Siener; Sara Glatz; Claudia Nicolay; Albrecht Hesse
Journal:  Obes Res       Date:  2004-01
View more
  4 in total

1.  Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells.

Authors:  Hyo-Jung Lee; Soo-Jin Jeong; Moon Nyeo Park; Michael Linnes; Hee Jeoung Han; Jin Hyoung Kim; John Charles Lieske; Sung-Hoon Kim
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

Review 2.  A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-19

3.  Microstructures of Randall's plaques and their interfaces with calcium oxalate monohydrate kidney stones reflect underlying mineral precipitation mechanisms.

Authors:  Ingo Sethmann; Gunnar Wendt-Nordahl; Thomas Knoll; Frieder Enzmann; Ludwig Simon; Hans-Joachim Kleebe
Journal:  Urolithiasis       Date:  2016-10-01       Impact factor: 3.436

4.  Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.

Authors:  Hans-Göran Tiselius; Bengt Lindbäck; Anne-Marie Fornander; Mari-Anne Nilsson
Journal:  Urol Res       Date:  2009-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.